相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Current and emerging drug treatment strategies for polycystic ovary syndrome
Nafiye Helvaci et al.
EXPERT OPINION ON PHARMACOTHERAPY (2023)
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
Han Zhao et al.
JOURNAL OF OVARIAN RESEARCH (2023)
Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)
Luigi Barrea et al.
CURRENT NUTRITION REPORTS (2023)
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Rok Herman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment
Chuan Xing et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2022)
Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
Karen E. Elkind-Hirsch et al.
FERTILITY AND STERILITY (2022)
GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons
Georgios S. Papaetis et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2022)
The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS
Xiaojia Li et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
The relationship between polycystic ovary syndrome and insulin resistance from 1983 to 2022: A bibliometric analysis
Tong Chen et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives
Mojca Jensterle et al.
BIOMEDICINES (2022)
Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists
Kosuke Sawami et al.
CARDIOVASCULAR DIABETOLOGY (2022)
The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis
Shuo Yang et al.
DRUGS (2022)
Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities
Shiying Shao et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations
Dan Xu et al.
CARDIOVASCULAR THERAPEUTICS (2022)
Therapy of obesity in women with PCOS using GLP-1-benefits and limitations
Agnieszka Baranowska-Bik
ENDOKRYNOLOGIA POLSKA (2022)
Glucagon-like peptide-1 control of GnRH secretion in female sheep
Leila Arbabi et al.
JOURNAL OF ENDOCRINOLOGY (2021)
A 2021 Update on the Use of Liraglutide in the Modern Treatment of 'Diabesity': A Narrative Review
Mariana Cornelia Tilinca et al.
MEDICINA-LITHUANIA (2021)
Clinical Impact of Liraglutide as a Treatment of Obesity
Heshma Alruwaili et al.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2021)
Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
Georgios S. Papaetis et al.
CLINICAL DRUG INVESTIGATION (2020)
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
Arianna Pani et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites
Zhihua Sun et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS)
Luigi Barrea et al.
NUTRIENTS (2019)
Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study
Vesna Salamun et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells
Yuki Nishiyama et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocyt es and Macrophages
Hiroki Yamazaki et al.
MEDIATORS OF INFLAMMATION (2018)
Glucagon-like peptide 1 in health and disease
Andreas Andersen et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Polycystic Ovary Syndrome
Ricardo Azziz
OBSTETRICS AND GYNECOLOGY (2018)
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
Signe Frossing et al.
ENDOCRINE CONNECTIONS (2018)
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial
Signe Frossing et al.
DIABETES OBESITY & METABOLISM (2018)
Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial
Malin Nylander et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
Mojca Jensterle et al.
BMC ENDOCRINE DISORDERS (2017)
Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential
Malin Nylander et al.
ENDOCRINE CONNECTIONS (2017)
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
A. Blackman et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells
Wenjing He et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Glucagon-Like Peptide-1 Excites Firing and Increases GABAergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (GnRH) Neurons of the Male Mice via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways
Imre Farkas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
Mojca Jensterle et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Polycystic ovary syndrome
Ricardo Azziz et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
GLP-1 Increases Preovulatory LH Source and the Number of Mature Follicles, As Well As Synchronizing the Onset of Puberty in Female Rats
Veronica Outeirino-Iglesias et al.
ENDOCRINOLOGY (2015)
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial
Melanie J. Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
Mojca Jensterle et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Exenatide improves ovarian and endometrial injury and preserves ovarian reserve in streptozocin induced diabetic rats
Burcu Artunc-Ulkumen et al.
GYNECOLOGICAL ENDOCRINOLOGY (2015)
A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
Mojca Jensterle et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2015)
Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome
Kadriye Aydin et al.
CLINICAL ENDOCRINOLOGY (2014)
Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
Mojca Jensterle Sever et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis
Liza Haqq et al.
ENDOCRINE CONNECTIONS (2014)
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
T. A. Wadden et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Evanthia Diamanti-Kandarakis et al.
ENDOCRINE REVIEWS (2012)
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
HUMAN REPRODUCTION UPDATE (2012)
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
A. Astrup et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Incretin levels in polycystic ovary syndrome
Jana Vrbikova et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Follicle dynamics and anovulation in polycystic ovary syndrome
Stephen Franks et al.
HUMAN REPRODUCTION UPDATE (2008)
The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome
Rebecca L. Thomson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
GLP-1 receptor expression in human tumors and human normal tissues:: Potential for in vivo targeting
Meike Koerner et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome
DA Ehrmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
T Apridonidze et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)